Regenerative endodontics represents a paradigm shift in the management of immature necrotic teeth, aiming to restore normal pulp-dentin function through biologically based procedures. This review provides an up-to-date synthesis of epidemiology, pathophysiology, clinical features, diagnostic criteria, treatment strategies, recent advances, and guideline-based recommendations in regenerative endodontics. Emphasis is placed on the integration of current literature, elucidating mechanisms underlying regenerative processes, and presenting practical clinical insights for healthcare professionals.
Endodontic management has traditionally focused on the removal of infected tissue and obturation of the root canal system. However, the emergence of regenerative endodontic procedures (REPs) has marked a transition towards biologically inspired strategies that promote healing and continued root development, especially in teeth with incomplete root formation. Regenerative endodontics harnesses stem cell biology, tissue engineering, and molecular signaling to restore the pulp-dentin complex, offering superior long-term outcomes over conventional apexification. This article reviews the latest scientific developments, clinical protocols, and future directions in regenerative endodontics to inform evidence-based practice among dental professionals.
The global incidence of dental trauma and caries in children and adolescents remains substantial, with a significant proportion leading to pulp necrosis in immature permanent teeth. Epidemiological studies indicate that up to 30% of dental injuries in children result in pulpal necrosis, often necessitating intervention. Traditional apexification procedures, while effective in resolving infection, fail to promote continued root development, leaving teeth prone to fracture. The burden of disease is particularly high in populations with limited access to timely dental care, underscoring the need for regenerative solutions that offer both biological and functional restoration.
Necrosis of the dental pulp in immature teeth interrupts the natural process of root maturation, leading to thin dentinal walls, open apices, and compromised structural integrity. The underlying pathophysiology involves disruption of the neurovascular supply, degeneration of odontoblastic and stem cell niches, and subsequent loss of odontogenic potential. Regenerative endodontics aims to reverse these changes by re-establishing a conducive environment for stem cell migration, proliferation, and differentiation, ultimately facilitating the regeneration of pulp-like tissue and promotion of dentinogenesis.
Major risk factors contributing to pulpal necrosis and the need for regenerative endodontics include traumatic dental injuries (particularly luxation and avulsion), deep dental caries, developmental anomalies, and iatrogenic factors such as over-instrumentation. Patient factors such as age, immune status, and genetic predispositions may also influence healing outcomes. Early intervention and appropriate case selection are crucial for optimizing the success of regenerative procedures.
Immature necrotic teeth commonly present with non-vital pulp, periapical radiolucency, incomplete root formation, open apices, and thin dentinal walls. Clinically, such teeth may be asymptomatic or exhibit signs of infection, including swelling, sinus tract formation, and tenderness to percussion. Radiographic assessment typically reveals halted root development with or without periapical pathology. Accurate identification of these features is vital for the selection of suitable cases for regenerative endodontic therapy.
Diagnosis is based on a combination of clinical examination, pulp vitality testing, and radiographic evaluation. Immature teeth with necrotic pulps and open apices are prime candidates for regenerative procedures. Contemporary diagnostic adjuncts, such as cone-beam computed tomography (CBCT), provide enhanced visualization of root development and periapical status. Microbiological assessment may also be employed in selected cases to guide antimicrobial protocols prior to regeneration attempts.
The standard protocol for regenerative endodontics involves minimal or no instrumentation, gentle chemical disinfection (commonly using sodium hypochlorite and EDTA), intracanal placement of bioactive medicaments (such as triple antibiotic paste or calcium hydroxide), and induction of a blood clot scaffold. This is followed by coronal sealing with biocompatible materials like mineral trioxide aggregate (MTA) or bioceramics. The success of REPs depends on the elimination of infection, preservation of stem cell viability, and creation of a suitable microenvironment for tissue regeneration. Patient follow-up typically involves serial clinical and radiographic monitoring for root maturation and periapical healing.
Recent advances in regenerative endodontics focus on optimizing scaffold materials, enhancing cellular recruitment, and leveraging growth factor delivery. The use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) as autologous scaffolds has demonstrated promising results in promoting healing and tissue regeneration. Bioengineered scaffolds incorporating stem cells from apical papilla (SCAP) and dental pulp stem cells (DPSC) are under investigation for their ability to recapitulate true pulp tissue. Molecular signaling agents, such as bone morphogenetic proteins and vascular endothelial growth factor, are being explored to augment the regenerative microenvironment. Additionally, gene therapy and nanotechnology hold future promise for personalized regenerative solutions.
Current guidelines from the American Association of Endodontists (AAE) and European Society of Endodontology (ESE) advocate for the use of REPs in immature necrotic teeth, emphasizing the importance of strict asepsis, minimal canal instrumentation, and appropriate use of intracanal medicaments. The guidelines recommend the avoidance of cytotoxic agents that may compromise stem cell viability and stress the need for regular follow-up to assess clinical and radiographic outcomes. Patient selection criteria and informed consent regarding potential outcomes and risks are also highlighted in recent consensus statements.
Regenerative endodontics has transformed the management of immature necrotic teeth, offering the potential for true biological repair and continued root development. Advances in stem cell biology, scaffold technology, and clinical protocols have enhanced the predictability of these procedures, although challenges remain in achieving consistent histological regeneration. Ongoing research and adherence to guideline-based protocols are essential for optimizing outcomes and translating emerging therapies into routine clinical practice. As the field evolves, regenerative endodontics stands poised to redefine the future of dental tissue engineering and patient care.
1.
Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries
2.
Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC
3.
Hereditary cancer has a rare and underreported cause.
4.
New imaging guidelines for head and neck cancers, a step toward practice change
5.
BMTs that are "half-matched" are effective in treating severe sickle cell disease.
1.
Oncolytic Adenoviruses Targeting PD-L1: Advancing Cancer Immunotherapy and Tumor Control
2.
Personalized Cancer Vaccines: The Next Frontier in Precision Oncology
3.
Essential Updates in Hematology in Daily Practice
4.
The Predictive Power of Theranostics in Palliative Neuroendocrine Tumor Management
5.
Importance of Early Detection in Oncology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
3.
Current Scenario of Cancer- The Incidence of Cancer in Men
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
5.
A New Era in Managing Cancer-Associated Thrombosis
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation